217 top medical experts on Glycogen Storage Disease Type III across 28 countries and 9 U.S. states, including 42 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Glycogen Storage Disease Type III: An autosomal recessive metabolic disorder due to deficient expression of amylo-1,6-glucosidase (one part of the glycogen debranching enzyme system). The clinical course of the disease is similar to that of glycogen storage disease type I, but milder. Massive hepatomegaly, which is present in young children, diminishes and occasionally disappears with age. Levels of glycogen with short outer branches are elevated in muscle, liver, and erythrocytes. Six subgroups have been identified, with subgroups Type IIIa and Type IIIb being the most prevalent.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Glycogen Storage Disease (1,538).
  4. Clinical Trials ClinicalTrials.gov : at least 9 including 1 Active, 2 Completed, 2 Recruiting
  5. Synonyms: Cori's Disease,  Debrancher Deficiency,  Forbes Disease,  Glycogen Debranching Enzyme Deficiency,  Glycogenosis 3,  Limit Dextrinosis


  

        

                    


    Computing Expert Listing ...

);